504 related articles for article (PubMed ID: 21304897)
1. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
[TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
3. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
[TBL] [Abstract][Full Text] [Related]
4. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
5. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
6. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
8. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
9. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat.
Narasimhan A; Chinnaiyan M; Karundevi B
Appl Physiol Nutr Metab; 2015 Aug; 40(8):769-81. PubMed ID: 26201855
[TBL] [Abstract][Full Text] [Related]
10. Fisetin improves glucose homeostasis through the inhibition of gluconeogenic enzymes in hepatic tissues of streptozotocin induced diabetic rats.
Prasath GS; Pillai SI; Subramanian SP
Eur J Pharmacol; 2014 Oct; 740():248-54. PubMed ID: 25064342
[TBL] [Abstract][Full Text] [Related]
11. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
12. Combretum lanceolatum flowers ethanol extract inhibits hepatic gluconeogenesis: an in vivo mechanism study.
Siqueira JT; Batistela E; Pereira MP; da Silva VC; de Sousa Junior PT; Andrade CM; Kawashita NH; Bertolini GL; Baviera AM
Pharm Biol; 2016 Sep; 54(9):1671-9. PubMed ID: 26864726
[TBL] [Abstract][Full Text] [Related]
13. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
14. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
15. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
16. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
17. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet.
Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N
Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
19. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
20. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
